| License: Creative Commons Attribution 4.0 PDF - Published Version (839kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-415411
- DOI to cite this document:
- 10.5283/epub.41541
Abstract
Background: Our aim was to evaluate the feasibility of a serological assessment of gastric cancer risk in patients undergoing colonoscopy in countries with low-to-moderate incidence rates. Methods: Serum samples were prospectively collected from 453 patients (>50 years old) undergoing colonoscopies. Of these, 279 (61.6%) also underwent gastroscopy to correlate the results for serum pepsinogen I ...
Owner only: item control page